[go: up one dir, main page]

SG11201902667UA - Methods and systems for chromatography data analysis - Google Patents

Methods and systems for chromatography data analysis

Info

Publication number
SG11201902667UA
SG11201902667UA SG11201902667UA SG11201902667UA SG11201902667UA SG 11201902667U A SG11201902667U A SG 11201902667UA SG 11201902667U A SG11201902667U A SG 11201902667UA SG 11201902667U A SG11201902667U A SG 11201902667UA SG 11201902667U A SG11201902667U A SG 11201902667UA
Authority
SG
Singapore
Prior art keywords
tarrytown
saw mill
river road
international
old saw
Prior art date
Application number
SG11201902667UA
Inventor
Nathan Mao
Eric Shierly
Bernhard Schilling
Scott Carver
Stefanie Mcdermott
John Mattila
Hanne Bak
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60269959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201902667U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11201902667UA publication Critical patent/SG11201902667UA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8603—Signal analysis with integration or differentiation
    • G01N30/8617—Filtering, e.g. Fourier filtering
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8693—Models, e.g. prediction of retention times, method development and validation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/889—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 monitoring the quality of the stationary phase; column performance

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mathematical Physics (AREA)
  • Algebra (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Pure & Applied Mathematics (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 111111101111 0 1110101011111 011101 0 011111a 0111111111H 111110 lil Oil lil Organization International Bureau (10) International Publication Number (43) International Publication Date .....0\"\" WO 2018/081203 Al 03 May 2018 (03.05.2018) WIP0 I PCT (51) International Patent Classification: eron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, GO1N 30/86 (2006.01) GO1N 30/88 (2006.01) Tarrytown, NY 10591 (US). MATTILA, John; C/o Regen- (21) International Application Number: eron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, PCT/US2017/058190 Tarrytown, NY 10591 (US). BAK, Hanne; C/o Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tar- (22) International Filing Date: rytown, NY 10591 (US). 25 October 2017 (25.10.2017) (74) Agent: RUSSELL, Thara; Bookoff Mcandrews, PLLC, (25) Filing Language: English 2020 K Street, Nw Suite 400, Washington, DC 20006 (US). (26) Publication Language: English (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (30) Priority Data: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, 62/412,563 25 October 2016 (25.10.2016) US CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (71) Applicant: REGENERON PHARMACEUTICALS, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, INC. [US/US]; 777 Old Saw Mill River Road, Tarrytown, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, NY 10591 (US). KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (72) Inventors: MAO, Nathan; C/o Regeneron Pharmaceuti- OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, cals, Inc., 777 Old Saw Mill River Road, Tarrytown, 10591 SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (US). SHIERLY, Eric; C/o Regeneron Pharmaceuticals, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. _ Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591 (US). SCHILLING, Bernhard; C/o Regeneron Pharma- (84) Designated States (unless otherwise indicated, for every ceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, kind of regional protection available): ARIPO (BW, GH, = NY 10591 (US). CARVER, Scott; C/o Regeneron Pharma- GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, ceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, = — NY 10591 (US). MCDERMOTT, Stefanie; C/o Regen- TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, = (54) Title: METHODS AND SYSTEMS FOR CHROMATOGRAPHY DATA ANALYSIS = FIG. 3 T . ---- -- 1 - = ca a) as -c 11 a) a5 Q o as 0 = = = GI a) c C Q / c a = - = 2 0 11 co -1T:1 _ — Cr) I / Il / M C 1_ _L 0 ei 1-1 GC Volume 0 .-- - GO (57) : Embodiments of the present disclosure are directed to methods and systems for assessing integrity of chromatography 1 -1 columns, systems, and processes. The methods and systems can comprise one or more of extracting a block and signal combination for 0 analysis, performing a transition analysis, performing one or more statistical process controls, and/or implementing in-process controls ei based on the statistical process controls. [Continued on next page] WO 2018/081203 Al D ill EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, SK, SM, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))
SG11201902667UA 2016-10-25 2017-10-25 Methods and systems for chromatography data analysis SG11201902667UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662412563P 2016-10-25 2016-10-25
PCT/US2017/058190 WO2018081203A1 (en) 2016-10-25 2017-10-25 Methods and systems for chromatography data analysis

Publications (1)

Publication Number Publication Date
SG11201902667UA true SG11201902667UA (en) 2019-05-30

Family

ID=60269959

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201902667UA SG11201902667UA (en) 2016-10-25 2017-10-25 Methods and systems for chromatography data analysis

Country Status (19)

Country Link
US (4) US10613063B2 (en)
EP (3) EP4575488A3 (en)
JP (4) JP7102401B2 (en)
KR (2) KR102564393B1 (en)
CN (3) CN114858957B (en)
AU (3) AU2017350807B2 (en)
BR (1) BR112019006689A2 (en)
CA (1) CA3039788A1 (en)
DK (2) DK4071469T3 (en)
EA (1) EA201990986A1 (en)
ES (2) ES2924060T3 (en)
FI (1) FI4071469T3 (en)
HU (2) HUE072096T2 (en)
IL (4) IL295211B2 (en)
MX (3) MX2019004316A (en)
PL (2) PL3532838T3 (en)
SG (1) SG11201902667UA (en)
WO (1) WO2018081203A1 (en)
ZA (1) ZA201902257B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3454058A4 (en) * 2016-03-14 2020-02-26 Shimadzu Corporation MASS SPECTROMETRY DATA ANALYSIS DEVICE AND PROGRAM FOR MASS SPECTROMETRY DATA ANALYSIS
BR112019006689A2 (en) * 2016-10-25 2019-06-25 Regeneron Pharma methods and systems for chromatography data analysis
US10634653B2 (en) * 2016-11-28 2020-04-28 Dionex Corporation Systems, methods and devices for width-based analysis of peak traces
KR102853122B1 (en) * 2018-04-20 2025-09-01 얀센 바이오테크 인코포레이티드 Qualification of chromatography columns in a manufacturing method for producing anti-TNF antibody compositions
CN109100441B (en) * 2018-08-23 2021-05-07 西南科技大学 Method for removing pulse interference of liquid chromatography curve
JP6791216B2 (en) * 2018-08-28 2020-11-25 横河電機株式会社 Monitoring programs, monitoring equipment, and monitoring systems
GB201909274D0 (en) * 2019-06-27 2019-08-14 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
CN110988232A (en) * 2019-11-28 2020-04-10 南通乐尔环保科技有限公司 Chromatographic baseline noise reduction method and device
JP7452186B2 (en) * 2020-03-30 2024-03-19 東ソー株式会社 How to estimate the operating status of a chromatograph
BR112022020822A2 (en) * 2020-04-14 2022-11-29 Regeneron Pharma ULTRAVIOLET PERFORMANCE MONITORING OF ORTHOGONAL PARTIAL Least SQUARES CHROMATOGRAPHY
JP2022091322A (en) * 2020-12-09 2022-06-21 株式会社島津製作所 SYSTEM AND PROGRAM FOR MANAGING pH OF LIQUID CHROMATOGRAPH
US11157644B1 (en) * 2020-12-15 2021-10-26 DataMover LLC Systems and methods of secure networked data exchange
CN112730712B (en) * 2020-12-31 2022-06-07 杭州谱育科技发展有限公司 Method for improving LC-MS data signal-to-noise ratio
JP7647205B2 (en) * 2021-03-17 2025-03-18 東ソー株式会社 Liquid chromatography device with quality control function
CN113321817A (en) * 2021-07-06 2021-08-31 青岛科技大学 Analysis method for key variables in nano lignin preparation process
EP4409279A1 (en) * 2021-09-28 2024-08-07 Merck Patent GmbH Methods for monitoring chromatography resins during continuous chromatography operation
JP7779170B2 (en) * 2022-02-24 2025-12-03 株式会社島津製作所 Chromatographic analysis device and chromatographic analysis program
CN115825313B (en) * 2023-02-22 2023-04-11 华谱科仪(北京)科技有限公司 Chromatographic information detection method, device, electronic equipment and computer readable medium
TW202528736A (en) 2023-09-08 2025-07-16 美商再生元醫藥公司 Methods and systems for assessing chromatographic column integrity

Family Cites Families (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190864A (en) 1986-04-15 1993-03-02 Northeastern University Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
US4801726A (en) 1986-04-15 1989-01-31 Northeastern University Repetitive hit-and-run immunoassay and stable support-analyte conjugates; applied to T-2 toxin
US4937188A (en) 1986-04-15 1990-06-26 Northeastern University Enzyme activity amplification method for increasing assay sensitivity
JPH07111423B2 (en) * 1986-10-01 1995-11-29 株式会社日立製作所 Chromatographic data processing method
JPS6486060A (en) * 1987-09-29 1989-03-30 Shimadzu Corp Analysis data processor
US5412083A (en) 1992-04-16 1995-05-02 Northeastern University Carbohydrate heterobifunctional cross-linking reagent
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
AU4986596A (en) 1995-02-16 1996-09-04 Massachusetts Health Research Institute, Inc. Purified tetanus toxoid and toxin
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
JP3180010B2 (en) * 1995-10-13 2001-06-25 株式会社日立製作所 Chromatographic analyzer
KR19990056559A (en) * 1997-12-29 1999-07-15 윤종용 Noise reduction method and device
EP0964057B1 (en) 1998-05-11 2004-12-22 Tosoh Corporation Method for separating nucleic acids by means of liquid chromatography
US7070959B1 (en) 1999-06-08 2006-07-04 Regeneron Pharmaceuticals, Inc. Modified chimeric polypeptides with improved pharmacokinetic properties
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
US7306799B2 (en) 1999-06-08 2007-12-11 Regeneron Pharmaceuticals, Inc. Use of VEGF inhibitors for treatment of eye disorders
US7303746B2 (en) 1999-06-08 2007-12-04 Regeneron Pharmaceuticals, Inc. Methods of treating eye disorders with modified chimeric polypeptides
ES2332402T5 (en) 2000-10-12 2018-05-14 Genentech, Inc. Concentrated protein formulations of reduced viscosity
US20020064860A1 (en) 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
US7101982B2 (en) 2001-03-30 2006-09-05 Immunex Corporation Control of ph transitions during chromatography
US6816789B2 (en) * 2001-04-19 2004-11-09 Varian, Inc. Method and system for analyzing chromatograms
WO2004020971A2 (en) 2002-08-28 2004-03-11 Introgen Therapeutics Inc. Chromatographic methods for adenovirus purification
WO2004024284A2 (en) 2002-09-13 2004-03-25 Biogen Idec Inc. Method of purifying polypeptides by simulated moving bed chromatography
US20060257972A1 (en) 2003-03-31 2006-11-16 Takashi Ishihara Purification of human monoclonal antibody and human polyclonal antibody
AU2004252171B2 (en) 2003-06-27 2011-04-21 Biogen Ma Inc. Modified binding molecules comprising connecting peptides
EP1687328B1 (en) 2003-10-24 2010-03-31 Amgen, Inc. Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
SE0400501D0 (en) 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
CA2552639C (en) 2004-02-27 2012-05-01 Ge Healthcare Bio-Sciences Ab A process for the purification of antibodies
SE0400886D0 (en) 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
US7795405B2 (en) 2004-08-09 2010-09-14 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
WO2006020622A1 (en) 2004-08-09 2006-02-23 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
JP4831436B2 (en) 2004-10-21 2011-12-07 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ Chromatographic ligand
US7303748B2 (en) 2005-02-02 2007-12-04 Regeneron Pharmaceuticals, Inc. Method of treating eye injury with local administration of a VEGF inhibitor
US20080299671A1 (en) 2005-12-02 2008-12-04 Ge Healthcare Bio-Sciences Ab Hydrophobic Interaction Chromatography
JP2009531371A (en) 2006-03-28 2009-09-03 エフ．ホフマン−ラ ロシュ アーゲー Anti-IGF-1R human monoclonal antibody preparation
NZ611859A (en) 2006-04-05 2014-12-24 Abbvie Biotechnology Ltd Antibody purification
PT2944306T (en) 2006-06-16 2021-02-15 Regeneron Pharma Vegf antagonist formulations suitable for intravitreal administration
WO2008028974A1 (en) 2006-09-08 2008-03-13 Novo Nordisk A/S Methods of optimizing chromatographic separation of polypeptides
JP2010505874A (en) 2006-10-03 2010-02-25 ノヴォ ノルディスク アー／エス Purification method for polypeptide conjugates
US20080299545A1 (en) 2007-03-06 2008-12-04 Shuyuan Zhang Chromatographic methods for assessing adenovirus purity
US8003364B2 (en) 2007-05-14 2011-08-23 Bavarian Nordic A/S Purification of vaccinia viruses using hydrophobic interaction chromatography
WO2009058769A1 (en) 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
WO2009094203A2 (en) 2008-01-25 2009-07-30 Biogen Idec Ma Inc. Automated system and method for monitoring chromatography column performance, and applications thereof
US7897405B2 (en) 2008-02-11 2011-03-01 Thermo Finnigan Llc Method for identifying the elution time of an analyte
US20090277254A1 (en) * 2008-05-09 2009-11-12 Medlmmune, Llc Methods of improving packed-bed chromatography performance
WO2010019814A1 (en) * 2008-08-15 2010-02-18 Biogen Idec Ma Inc. Methods for evaluating chromatography column performance
US20100069617A1 (en) 2008-09-12 2010-03-18 Ge Healthcare Bio-Sciences Ab Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
CN104974251A (en) 2008-10-20 2015-10-14 Abbvie公司 Viral inactivation during purification of antibodies
CN105111309A (en) 2008-10-20 2015-12-02 Abbvie公司 Isolation and purification of antibodies using protein an appinity chromatography
WO2010129469A1 (en) 2009-05-04 2010-11-11 Abbott Biotechnology Ltd. Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
JP5956331B2 (en) 2009-06-16 2016-07-27 ジェンザイム・コーポレーション Improved purification method for recombinant AAV vectors
WO2011028961A2 (en) 2009-09-04 2011-03-10 Xoma Technology Ltd. Anti-botulism antibody coformulations
MX341136B (en) 2009-10-20 2016-08-09 Abbvie Inc Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography.
US8246833B2 (en) 2009-12-17 2012-08-21 Ge Healthcare Bio-Sciences Ab Chromatography column and maintenance method
KR20120118065A (en) 2010-02-12 2012-10-25 디에스엠 아이피 어셋츠 비.브이. Single unit antibody purification
EP2580772B1 (en) * 2010-06-10 2015-03-11 International Business Machines Corporation A method computer program and system to analyze mass spectra
WO2012030512A1 (en) 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
JP5919606B2 (en) 2010-11-11 2016-05-18 アッヴィ バイオテクノロジー リミテッド Improved high concentration anti-TNF alpha antibody liquid formulation
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
WO2012129535A1 (en) * 2011-03-24 2012-09-27 Indigo Biosystems, Inc. Syntactical system and method for chromatographic peak identification
HUP1100312A2 (en) * 2011-06-14 2013-01-28 Emil Dr Mincsovics Procedure and equipment for improving of performance characteristics of column chromatography separation processes
US9943594B2 (en) 2011-10-11 2018-04-17 Sanofi Biotechnology Methods for the treatment of rheumatoid arthritis
TWI589299B (en) 2011-10-11 2017-07-01 再生元醫藥公司 Composition for treating rheumatoid arthritis and method of use thereof
EP2773439A4 (en) 2011-10-31 2015-07-01 Merck Sharp & Dohme CHROMATOGRAPHY METHOD FOR DECOMPOSING HETEROGENEOUS ANTIBODY AGGREGATES
WO2013074557A1 (en) 2011-11-14 2013-05-23 Regeneron Pharmaceuticals, Inc. Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing gdf8 and/or activin a
CN104066748A (en) 2011-11-21 2014-09-24 霍夫曼-拉罗奇有限公司 Purification of anti-c-met antibody
BR112014011900A2 (en) 2011-12-15 2017-05-16 Hanwha Chemical Corp an antibody purification method
US20150051843A1 (en) * 2012-01-16 2015-02-19 Leco Corporation Systems and Methods to Process Data in Chromatographic Systems
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
WO2013177115A2 (en) 2012-05-21 2013-11-28 Abbvie Inc. Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography
US20140154270A1 (en) 2012-05-21 2014-06-05 Chen Wang Purification of non-human antibodies using kosmotropic salt enhanced protein a affinity chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
US8941405B2 (en) 2012-08-03 2015-01-27 International Business Machines Corporation FET pair based physically unclonable function (PUF) circuit with a constant common mode voltage
EP2879691B1 (en) 2012-08-06 2019-03-27 Biogen MA Inc. Methods for inactivating enveloped viruses
US9650411B2 (en) 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
CA2895198A1 (en) 2012-12-20 2014-06-26 Medimmune, Llc Liquid antibody formulation with improved aggregation properties
IL274646B (en) 2013-03-08 2022-09-01 Genzyme Corp Integrated continuous manufacturing of therapeutic protein drug substances
EP2830651A4 (en) 2013-03-12 2015-09-02 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
CA2926384A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. Low acidic species compositions and methods for producing and using the same
TWI670279B (en) 2013-03-15 2019-09-01 美商艾爾德生物製藥股份有限公司 Antibody purification and purity monitoring
US9994609B2 (en) 2013-03-15 2018-06-12 Biogen Ma Inc. Hydrophobic interaction protein chromatography under no-salt conditions
PL2981822T3 (en) 2013-05-06 2021-07-12 Scholar Rock, Inc. COMPOSITIONS AND METHODS OF MODULATION OF THE GROWTH FACTOR
TWI682780B (en) 2013-05-30 2020-01-21 美商再生元醫藥公司 Use of a pharmaceutical composition for the manufacture of a medicament for treating autosomal dominant hypercholesterolemia associated with pcsk9 gain-of-function mutations
US10111953B2 (en) 2013-05-30 2018-10-30 Regeneron Pharmaceuticals, Inc. Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
TWI755763B (en) 2013-06-04 2022-02-21 美商再生元醫藥公司 Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r inhibitor
KR101569783B1 (en) 2013-06-05 2015-11-19 한화케미칼 주식회사 A Method of Antibody Purification
US9150938B2 (en) 2013-06-12 2015-10-06 Orochem Technologies, Inc. Tagatose production from deproteinized whey and purification by continuous chromatography
TWI596107B (en) 2013-06-25 2017-08-21 卡地拉保健有限公司 Novel purification process for monoclonal antibodies
RU2016112549A (en) 2013-09-05 2017-10-10 Дженентек, Инк. METHOD FOR RE-USING CHROMATOGRAPHY
ES2915378T3 (en) 2013-09-13 2022-06-22 Hoffmann La Roche Methods for detecting and quantifying a host cell protein in cell lines
KR102571391B1 (en) 2013-09-13 2023-08-29 제넨테크, 인크. Methods and compositions comprising purified recombinant polypeptides
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
JP2016538267A (en) 2013-10-25 2016-12-08 メディミューン，エルエルシー Antibody purification
US10115576B2 (en) 2013-12-12 2018-10-30 Waters Technologies Corporation Method and an apparatus for analyzing a complex sample
CN103616458B (en) * 2013-12-14 2015-05-27 环境保护部南京环境科学研究所 Method for quantitatively detecting six kinds of nitrobenzene compounds in fine atmospheric particles PM2.5
JP6260351B2 (en) * 2014-03-04 2018-01-17 株式会社島津製作所 Chromatograph data processing apparatus and data processing method
JO3701B1 (en) 2014-05-23 2021-01-31 Regeneron Pharma Human antibodies to middle east respiratory syndrome – coronavirus spike protein
FR3025515B1 (en) 2014-09-05 2016-09-09 Lab Francais Du Fractionnement PROCESS FOR PURIFYING MONOCLONAL ANTIBODY
TW201628649A (en) 2014-10-09 2016-08-16 再生元醫藥公司 Method for reducing microscopic particles in a pharmaceutical formulation
AU2015355150A1 (en) 2014-12-02 2017-06-08 Regeneron Pharmaceuticals, Inc. Methods for treating dry eye disease by administering an IL-6R antagonist
EP3247718B1 (en) 2015-01-21 2021-09-01 Outlook Therapeutics, Inc. Modulation of charge variants in a monoclonal antibody composition
TWI710573B (en) 2015-01-26 2020-11-21 美商再生元醫藥公司 Human antibodies to ebola virus glycoprotein
CN104748764B (en) * 2015-04-01 2017-05-24 清华大学 Method for calibrating space angle of acoustic image plane in acoustic field visualization system
TWI756187B (en) 2015-10-09 2022-03-01 美商再生元醫藥公司 Anti-lag3 antibodies and uses thereof
BR112018012801B1 (en) 2015-12-22 2024-03-12 Regeneron Pharmaceuticals, Inc USES OF A COMBINATION OF ANTI-PD-1 ANTIBODIES AND ANTI-CD20/ANTI-CD3 BIESPECIFIC ANTIBODIES AND OF A PHARMACEUTICAL COMPOSITION
KR20180087401A (en) 2015-12-22 2018-08-01 리제너론 파아마슈티컬스, 인크. Dual-specific anti-CD20 / anti-CD3 antibodies for the treatment of acute lymphoblastic leukemia
EP3184119A1 (en) 2015-12-23 2017-06-28 Themis Bioscience GmbH Chromatography based purification strategies for measles scaffold based viruses
GB201602938D0 (en) 2016-02-19 2016-04-06 Ucb Biopharma Sprl Protein purification
US10353868B2 (en) * 2016-04-11 2019-07-16 RMC Pharmaceutical Solutions, Inc. Methods and systems for event based notifications
BR112018075667B1 (en) 2016-06-14 2024-02-20 Biogen Ma, Inc Methods for separating a target oligonucleotide from a mixture containing the target oligonucleotide and a product-related impurity
WO2018027195A1 (en) 2016-08-05 2018-02-08 Abbvie Biotherapeutics Inc. Compositions containing reduced amounts of daclizumab acidic isoforms and methods for preparing the same
BR112019006689A2 (en) * 2016-10-25 2019-06-25 Regeneron Pharma methods and systems for chromatography data analysis
US10626376B2 (en) 2016-11-14 2020-04-21 St. Jude Children's Research Hospital Method for isolating and purifying adeno-associated virus particles using salt
US11697670B2 (en) 2017-08-22 2023-07-11 Biogen Ma Inc. Methods for purifying antibodies having reduced high molecular weight aggregates
US12325875B2 (en) 2018-03-16 2025-06-10 Bristol-Myers Squibb Company Metabolic enzyme activity and disulfide bond reduction during protein production
WO2019178495A1 (en) 2018-03-16 2019-09-19 Biogen Ma Inc. Methods for purifying recombinant adeno-associated viruses
WO2019191416A1 (en) 2018-03-29 2019-10-03 Bristol-Myers Squibb Company Methods of purifying monomeric monoclonal antibodies
CN112566930A (en) 2018-06-19 2021-03-26 百时美施贵宝公司 Method for purifying proteins using chromatography
TWI853823B (en) 2018-07-02 2024-09-01 美商里珍納龍藥品有限公司 Systems and methods for preparing a polypeptide from a mixture
US20220267369A1 (en) 2018-07-25 2022-08-25 Merck Sharp & Dohme Corp. Methods of separating host cell lipases from a production protein in chromatographic processes
CN112805300A (en) 2018-08-15 2021-05-14 百时美施贵宝公司 Protein fragmentation control strategy based on reoxidation in downstream chromatography
CN113301922A (en) 2018-11-05 2021-08-24 百时美施贵宝公司 Method for purifying pegylated proteins
US20220135619A1 (en) 2019-02-24 2022-05-05 Bristol-Myers Squibb Company Methods of isolating a protein
CN113646630B (en) 2019-03-29 2024-05-07 百时美施贵宝公司 Method for measuring hydrophobicity of chromatographic resin
CN114173827B (en) 2019-06-28 2025-01-28 武田药品工业株式会社 Adeno-associated virus purification method

Also Published As

Publication number Publication date
EP3532838A1 (en) 2019-09-04
KR20190073396A (en) 2019-06-26
ZA201902257B (en) 2020-11-25
IL295211B2 (en) 2024-09-01
WO2018081203A1 (en) 2018-05-03
US10613063B2 (en) 2020-04-07
FI4071469T3 (en) 2025-07-17
AU2022246438B2 (en) 2024-12-12
IL265874A (en) 2019-06-30
US20220308025A1 (en) 2022-09-29
CN114858957B (en) 2024-11-22
EP4575488A3 (en) 2025-08-20
IL312194A (en) 2024-06-01
MX2023009743A (en) 2023-08-30
HUE072096T2 (en) 2025-10-28
AU2017350807A1 (en) 2019-04-18
US20180113101A1 (en) 2018-04-26
JP7102401B2 (en) 2022-07-19
IL289895A (en) 2022-03-01
EP4575488A2 (en) 2025-06-25
JP2024028600A (en) 2024-03-04
KR102759512B1 (en) 2025-02-03
BR112019006689A2 (en) 2019-06-25
JP2025161934A (en) 2025-10-24
ES3032778T3 (en) 2025-07-24
EP4071469A3 (en) 2022-12-14
US11333642B2 (en) 2022-05-17
US20230273163A1 (en) 2023-08-31
AU2024266951A1 (en) 2024-12-19
CA3039788A1 (en) 2018-05-03
KR102564393B1 (en) 2023-08-08
JP2020500299A (en) 2020-01-09
AU2022246438A1 (en) 2022-11-03
JP7427721B2 (en) 2024-02-05
EA201990986A1 (en) 2019-09-30
IL295211A (en) 2022-10-01
JP7734769B2 (en) 2025-09-05
CN114858957A (en) 2022-08-05
HUE059631T2 (en) 2022-12-28
PL3532838T3 (en) 2022-10-03
IL265874B (en) 2022-02-01
CN109923411B (en) 2022-05-31
DK3532838T3 (en) 2022-07-04
MX2019004316A (en) 2019-08-05
PL4071469T3 (en) 2025-07-28
EP3532838B1 (en) 2022-06-01
CN119492842A (en) 2025-02-21
MX2023009744A (en) 2023-08-30
IL295211B1 (en) 2024-05-01
IL289895B (en) 2022-09-01
US20200191756A1 (en) 2020-06-18
US11680930B2 (en) 2023-06-20
KR20230119729A (en) 2023-08-16
CN109923411A (en) 2019-06-21
ES2924060T3 (en) 2022-10-04
EP4071469A2 (en) 2022-10-12
DK4071469T3 (en) 2025-06-30
JP2022125254A (en) 2022-08-26
AU2017350807B2 (en) 2022-07-07
EP4071469B1 (en) 2025-04-09

Similar Documents

Publication Publication Date Title
SG11201902667UA (en) Methods and systems for chromatography data analysis
SG11201906875RA (en) Ultra-reliable low-latency communication indication channelization designs
SG11201907090WA (en) Affine motion information derivation
SG11201804696RA (en) Techniques for metadata processing
SG11201804190YA (en) Method and system for blockchain variant using digital signatures
SG11201901577SA (en) Method and system for fast tracking navigation of blockchains via data manipulation
SG11201904942YA (en) Blockchain-based service execution method and apparatus, and electronic device
SG11201811740WA (en) Systems and methods for identifying risky driving behavior
SG11201900269XA (en) Channel sensing for independent links
SG11201808990QA (en) Compositions for topical application of compounds
SG11201909903VA (en) Containerized deployment of microservices based on monolithic legacy applications
SG11201811608TA (en) Systems and methods for transportation service safety assessment
SG11201901006RA (en) Systems and methods for enhanced organizational transparency using a credit chain
SG11201907668PA (en) Segment types as delimiters and addressable resource identifiers
SG11201806650VA (en) Systems and methods for providing a personal distributed ledger
SG11201806738PA (en) Using luma information for chroma prediction with separate luma-chroma framework in video coding
SG11201806404SA (en) Systems and methods for storing and sharing transactional data using distributed computer systems
SG11201809872TA (en) Using hardware based secure isolated region to prevent piracy and cheating on electronic devices
SG11201811604UA (en) System and method for real-time transcription of an audio signal into texts
SG11201408665XA (en) Two stage gasification with dual quench
SG11201810525XA (en) Anti-gitr antibodies and uses thereof
SG11201908260WA (en) Device, system, and method for facilitating communications between electronic gaming machines and mobile devices
CA3015078A1 (en) Extended synchronization signal for symbol index detection
SG11201906630SA (en) Wellhead assembly and method
SG11201907259YA (en) Binary arithmetic coding with parameterized probability estimation finite state machines